Back to Results
First PageMeta Content
Biotechnology / Immunology / Genentech / South San Francisco / California / Trastuzumab / Breast cancer treatment / Hoffmann-La Roche / Breast cancer / Severin Schwan / Medicine / Ribbon symbolism / Biology


 Annual General Meeting Roche Holding Ltd 5 March 2013
Add to Reading List

Document Date: 2013-03-05 07:05:44

Open Document

File Size: 462,76 KB

Share Result on Facebook

Company

Annual General Meeting Roche Holding Ltd / Amgen / Boehringer Mannheim / Novo Nordisk / Genentech / /

Country

Switzerland / United States / /

Currency

CHF / /

Event

Dividend Issuance / FDA Phase / M&A / /

Facility

Roche Institute / Basel Institute / /

IndustryTerm

chemical drugs / biotech products / pharmaceutical sales / treatment of HER2-positive breast cancer / pharmaceuticals / biotechnology / biotechnology mean / treatment of breast cancer / treatment of cancer / treatment of metastatic HER2-positive breast cancer / cancer treatment / breast cancer treatment / /

MedicalCondition

cancers / cancer / disease / standard cancer / metastatic HER2-positive breast cancer / nausea / targeted cancer / HER2-positive breast cancer / breast cancer / /

MedicalTreatment

Chemotherapy / /

Organization

Basel Institute for Immunology / US Food and Drug Administration / Roche Institute for Molecular Biology / Basel Institute / European Union / /

Person

Georges Köhler / /

Position

Severin Schwan Chief Executive Officer / market leader / /

Product

Herceptin / Rituxan / European Union / DM1 / /

PublishedMedium

Molecular Biology / /

Technology

biopharmaceuticals / diagnostic tests / antibodies / biotechnology / Chemotherapy / drug development / /

SocialTag